Cancer Res.2015, 75, 5–10. Abdou, P.; Wang, Z. J.; Chen, Q.; Chan, A.; Zhou, D. R.; Gunadhi, V.; Gu, Z. Protein@inorganic nanodumpling system for high-loading protein delivery with activatable fluorescence and magnetic resonance bimodal imaging capabilities. Acute cellular and vascular responses to photodynamic therapy using egfr-targeted nanobody-photosensitizer conjugates studied with intravital optical imaging and magnetic resonance imaging. Adv. Iran. Combined nivolumab and ipilimumab or monotherapy in untreated melanoma. Galluzzi, L.; Vacchelli, E.; Bravo-San Pedro, J. M.; Buqué, A.; Senovilla, L.; Baracco, E. E.; Bloy, N.; Castoldi, F.; Abastado, J. P.; Agostinis, P. et al. Commun.2019, 10, 3838. Makkouk, A.; Weiner, G. J. MHC-II neoantigens shape tumour immunity and response to immunotherapy. ACS Nano2019, 13, 12671–12686. Sci.2020, 8, 2344–2365. Tumor-targeted drug and CpG delivery system for phototherapy and docetaxel-enhanced immunotherapy with polarization toward M1-type macrophages on triple negative breast cancers. Rev. HiPIMS Deposited Ti-Cu Thin Films and Their Antibacterial Activity. Goldberg, M. S. Improving cancer immunotherapy through nanotechnology. Kubik, T.; Bogunia-Kubik, K.; Sugisaka, M. Nanotechnology on duty in medical applications. Zhiqiang Tao, Sheng Li, Zhaowen Wang, Chen Fang, Longqi Yang, Handong Zhao, Yun Fu (2019). ACS Nano2019, 13, 4209–4219. Biol.2016, 50, 705–709. Vodnala, S. K.; Eil, R.; Kishton, R. J.; Sukumar, M.; Yamamoto, T. N.; Ha, N. H.; Lee, P. H.; Shin, M.; Patel, S. J.; Yu, Z. Y. et al. Nanomedicine2020, 15, 625–641. Smith, T. T.; Stephan, S. B.; Moffett, H. F.; McKnight, L. E.; Ji, W. H.; Reiman, D.; Bonagofski, E.; Wohlfahrt, M. E.; Pillai, S. P. S.; Stephan, M. T. In situ programming of leukaemia-specific t cells using synthetic DNA nanocarriers. Kranz, L. M.; Diken, M.; Haas, H.; Kreiter, S.; Loquai, C.; Reuter, K. C.; Meng, M.; Fritz, D.; Vascotto, F.; Hefesha, H. et al. Endosomolytic polymersomes increase the activity of cyclic dinucleotide sting agonists to enhance cancer immunotherapy. Mater.2018, 30, 1803163. Gastroenterology2018, 155, 29–32. Huang, Y. H.; Zhu, C.; Kondo, Y.; Anderson, A. C.; Gandhi, A.; Russell, A.; Dougan, S. K.; Petersen, B. S.; Melum, E.; Pertel, T. et al. Wang, S.; Liu, X.; Chen, S. Z.; Liu, Z. R.; Zhang, X. D.; Liang, X. J.; Li, L. L. Regulation of Ca2+ signaling for drug-resistant breast cancer therapy with mesoporous silica nanocapsule encapsulated doxorubicin/sirna cocktail. National Cheng Kung University Department of Chemical Engineering Mailing Address: Department of Chemical Engineering 1 University Road Tainan, Taiwan 70148 Nanotechnol.2017, 12, 648–654. Okabe, Y.; Medzhitov, R. Tissue-specific signals control reversible program of localization and functional polarization of macrophages. Acta Biomater.2020, 101, 43–68. Desale, S. S.; Raja, S. M.; Kim, J. O.; Mohapatra, B.; Soni, K. S.; Luan, H. T.; Williams, S. H.; Bielecki, T. A.; Feng, D.; Storck, M. et al. Adv. If you do not receive an email within 10 minutes, your email address may not be registered, Sakaguchi, S.; Mikami, N.; Wing, J. Cancer immunotherapy via dendritic cells. B2020, 8, 1396–1404. Immunity2013, 39, 1–10. Mol. Lewis, C. E.; Pollard, J. W. Distinct role of macrophages in different tumor microenvironments. A.; Strijkers, G. J.; Van Diest, P. J.; Lowik, C. W. G. M.; Seynhaeve, A. L. B.; Ten Hagen, T. L. M.; Prompers, J. J. et al. Tax calculation will be finalised during checkout. Zhang, B.; Jin, K.; Jiang, T.; Wang, L. T.; Shen, S.; Luo, Z. M.; Tuo, Y. Y.; Liu, X. P.; Hu, Y.; Pang, Z. Q. Celecoxib normalizes the tumor microenvironment and enhances small nanotherapeutics delivery to A549 tumors in nude mice. J. Chen, Q.; Hu, Q. Y.; Dukhovlinova, E.; Chen, G. J.; Ahn, S.; Wang, C.; Ogunnaike, E. A.; Ligler, F. S.; Dotti, G.; Gu, Z. Photothermal therapy promotes tumor infiltration and antitumor activity of CAR T cells. Zhou, J. R.; Kroll, A. V.; Holay, M.; Fang, R. H.; Zhang, L. F. Biomimetic nanotechnology toward personalized vaccines. Immunol. Greenwald, R. J.; Freeman, G. J.; Sharpe, A. H. The B7 family revisited. Mol. Saeed, M.; Gao, J.; Shi, Y.; Lammers, T.; Yu, H. J. Adv. Sci. AllergoOncology: Opposite outcomes of immune tolerance in allergy and cancer. A Ratiometric Fluorescent Bioprobe Based on Carbon Dots and Acridone Derivate for Signal Amplification Detection Exosomal microRNA. CEACAM1 regulates TIM-3-mediated tolerance and exhaustion. 032. Mulder, W. J. M.; Ochando, J.; Joosten, L. A. Cell2015, 161, 205–214. A facile approach to enhance antigen response for personalized cancer vaccination. In the 25th ACM SIGKDD Conference on Knowledge Discovery and Data Mining (KDD). Int. Chen Lien-hung (Chinese: 陳連宏; pinyin: Chén Liánhóng), born 13 September 1973 in Tainan, Taiwan, is a Taiwanese former baseball player who played for Chinatrust Whales and Uni-President Lions of Chinese Professional Baseball League. Biomaterials2012, 33, 5776–5787. Acta Biomater.2016, 31, 186–196. Stephan, M. T.; Stephan, S. B.; Bak, P.; Chen, J. Nat. Rev. In situ dendritic cell vaccine for effective cancer immunotherapy. Wiley Interdiscip. J. Cancer2019, 144, 178–189. Cross-Batch Reference Learning for Deep Retrieval Huei-Fang Yang, Kevin Lin, Ting-Yen Chen, Chu-Song Chen IEEE Transactions on Neural … Sun, Q. H.; Zhou, Z. X.; Qiu, N. S.; Shen, Y. Q. B.; Song, L.; Ke, K. M.; Liu, Y. J.; Zhou, Z. J.; Shen, Z. Y.; Li, J.; Yang, Z.; Tang, W. et al. Biomed. Nano Lett.2019, 19, 6964–6976. Cell1998, 94, 715–725. Funct. CD44ICD promotes breast cancer stemness via PFKFB4-mediated glucose metabolism. Gulzar, A.; Xu, J. T.; Yang, D.; Xu, L. G.; He, F.; Gai, S. L.; Yang, P. P. Nano-graphene oxide-ucnp-ce6 covalently constructed nanocomposites for nir-mediated bioimaging and ptt/pdt combinatorial therapy. Enhanced Magnetic Properties of Pr-Fe-B Thin Films by Segregation of Cu at Grain Boundary. Adv. Oncotarget2014, 5, 12472–12508. Cancer2017, 16, 134. Steeland, S.; Vandenbroucke, R. E.; Libert, C. Nanobodies as therapeutics: Big opportunities for small antibodies. Enzyme-activatable polymer-drug conjugate augments tumour penetration and treatment efficacy. Activatable semiconducting theranostics: Simultaneous generation and ratiometric photoacoustic imaging of reactive oxygen species in vivo. A nanoparticle-incorporated STING activator enhances antitumor immunity in PD-L1-insensitive models of triple-negative breast cancer. Rev. Mater.2019, 8, 1801188. USA2010, 107, 20009–20014. Eng.2018, 2, 831–840. Nat. B.; Lan, C.; Zhang, S. R.; Yang, B. C. Titania-coated 2D gold nanoplates as nanoagents for synergistic photothermal/sonodynamic therapy in the second near-infrared window. Sheng Wang, Guocan Yu, Zhantong Wang, Orit Jacobson, Li‐Sen Lin, Weijing Yang, Hongzhang Deng, Zhimei He, Yuan Liu, Zhi‐Yi Chen, Xiaoyuan Chen, Enhanced Antitumor Efficacy by a Cascade of Reactive Oxygen Species Generation and Drug Release, Angewandte Chemie International Edition, 10.1002/anie.201908997, 58, 41, (14758-14763), (2019). Colzani, B.; Pandolfi, L.; Hoti, A.; Iovene, P. A.; Natalello, A.; Avvakumova, S.; Colombo, M.; Prosperi, D. Investigation of antitumor activities of trastuzumab delivered by plga nanoparticles. Larkin, J.; Chiarion-Sileni, V.; Gonzalez, R.; Grob, J. J.; Cowey, C. L.; Lao, C. D.; Schadendorf, D.; Dummer, R.; Smylie, M.; Rutkowski, P. et al. Nanobiotechnol.2019, 11, e1559. Wang, S.; Lin, J.; Wang, Z. T.; Zhou, Z. J.; Bai, R. L.; Lu, N.; Liu, Y. J.; Fu, X.; Jacobson, O.; Fan, W. P. et al. Designer vaccine nanodiscs for personalized cancer immunotherapy. Novel miRNA genes hypermethylated in breast cancer. Annu. Science2018, 359, 1361–1365. Nat. Hinrichs, C. S.; Rosenberg, S. A. Exploiting the curative potential of adoptive T-cell therapy for cancer. Adv. Cell2018, 175, 313–326. Chen, M. S.; Ouyang, H. C.; Zhou, S. Y.; Li, J. Y.; Ye, Y. Fire, A.; Xu, S. Q.; Montgomery, M. K.; Kostas, S. A.; Driver, S. E.; Mello, C. C. Potent and specific genetic interference by double-stranded rna in Caenorhabditis elegans. Ying-Hsiao Chen, Shin-Lei Lin, Yu-Chen Chang, Yung-Chung Chen, Jiann T. Lin, Rong-Ho Lee*, Wen-Jang Kuo, and Ru-Jong Jeng*. Biotechnol.2005, 6, 17–33. Transl. Tang, J.; Hubbard-Lucey, V. M.; Pearce, L.; O’Donnell-Tormey, J.; Shalabi, A. Chem. Lin, L. S.; Song, J. A.; Jensen, M. C.; Pun, S. H. Cell-templated silica microparticles with supported lipid bilayers as artificial antigen-presenting cells for T cell activation. Ma, T. C.; Liu, Y. D.; Wu, Q.; Luo, L. F.; Cui, Y. L.; Wang, X. H.; Chen, X. W.; Tan, L. F.; Meng, X. W. Quercetin-modified metal-organic frameworks for dual sensitization of radiotherapy in tumor tissues by inhibiting the carbonic anhydrase IX. A.; Liu, X.; Bajwa, S. Z.; Khan, W. S.; Yu, H. J. Stimuli-activatable nanomedicines for chemodynamic therapy of cancer. ACS Nano2019, 13, 12357–12371. A novel technology using nanomaterials may bring a … ACS Nano2020, 14, 2172–2182. B.; Rizos, H.; Tao, W.; Zheng, M. et al. Tumor targeting strategies of smart fluorescent nanoparticles and their applications in cancer diagnosis and treatment. Hydrogenation, on the other hand, is accomplished at temperatures as low as 303 K. As a service to our authors and readers, this journal provides supporting information supplied by the authors. Int. Cun, X. L.; Ruan, S. B.; Chen, J. T.; Zhang, L.; Li, J. P.; He, Q.; Gao, H. L. A dual strategy to improve the penetration and treatment of breast cancer by combining shrinking nanoparticles with collagen depletion by losartan. J. Hassani, M.; Hajari Taheri, F.; Sharifzadeh, Z.; Arashkia, A.; Hadjati, J.; Van Weerden, W. M.; Abdoli, S.; Modarressi, M. H.; Abolhassani, M. Engineered jurkat cells for targeting prostate-specific membrane antigen on prostate cancer cells by nanobody-based chimeric antigen receptor. Yaokun Xia, Liangliang Wang, Juan Li, Xiangqi Chen, Jianming Lan, An Yan, Yun Lei, Sheng Yang, Huanghao Yang, Jinghua Chen. Chem. Cancer2017, 17, 20–37. Song, S. L.; Jin, X. X.; Zhang, L.; Zhao, C.; Ding, Y.; Ang, Q. Q.; Khaidav, O.; Shen, C. L. Pegylated and CD47-conjugated nano-ellipsoidal artificial antigen-presenting cells minimize phagocytosis and augment anti-tumor t-cell responses. Liu, D. C.; Chen, B. L.; Mo, Y. L.; Wang, Z. H.; Qi, T.; Zhang, Q.; Wang, Y. G. Redox-activated porphyrin-based liposome remote-loaded with indoleamine 2,3-dioxygenase (IDO) inhibitor for synergistic photoimmunotherapy through induction of immunogenic cell death and blockage of ido pathway. Cancer immunoediting: Integrating immunity’s roles in cancer suppression and promotion. A.; Vadlamani, S.; Vemula, K.; Vunnum, S.; Satyam, L. K.; Samiulla, D. S.; Subbarao, K. et al. These papers can be cited using the date of access and the unique DOI number. Med.2007, 3, 103–110. Working off-campus? Mater.2017, 29, 1606628. Ferlay, J.; Soerjomataram, I.; Dikshit, R.; Eser, S.; Mathers, C.; Rebelo, M.; Parkin, D. M.; Forman, D.; Bray, F. Cancer incidence and mortality worldwide: Sources, methods and major patterns in globocan 2012. Nature2017, 541, 417–420. Systemic rna delivery to dendritic cells exploits antiviral defence for cancer immunotherapy. It aims to stimulate the innate and adaptive immune system of a patient to fight against tumor cells. Schmid, P.; Adams, S.; Rugo, H. S.; Schneeweiss, A.; Barrios, C. H.; Iwata, H.; Dieras, V.; Hegg, R.; Im, S. A.; Shaw Wright, G. et al. Palucka, K.; Banchereau, J. Conde, J.; Bao, C. C.; Tan, Y. Q.; Cui, D. X.; Edelman, E. R.; Azevedo, H. S.; Byrne, H. J.; Artzi, N.; Tian, F. R. Dual targeted immunotherapy via in vivo delivery of biohybrid RNAi-peptide nanoparticles to tumor-associated macrophages and cancer cells. Nanomedicine. Chem. A.; Netea, M. G. Therapeutic targeting of trained immunity. Public Health2018, 46, 27–36. Nat. Cell Rep.2015, 11, 957–966. Sci. B. STING: A master regulator in the cancer-immunity cycle. Radiology2019, 290, 9–22. Xu, X.; Li, T.; Shen, S. Y.; Wang, J. Q.; Abdou, P.; Gu, Z.; Mo, R. Advances in engineering cells for cancer immunotherapy. VISTA is a checkpoint regulator for naive T cell quiescence and peripheral tolerance. 033. Shen Lin was born on October 23, 1980 in Beijing, China. Pharm. Med.2010, 16, 1035–1041. Rev. Chem.1948, 175, 315–332. Sahai, E.; Astsaturov, I.; Cukierman, E.; DeNardo, D. G.; Egeblad, M.; Evans, R. M.; Fearon, D.; Greten, F. R.; Hingorani, S. R.; Hunter, T. et al. Jay Prakash, Zhijian Yang, Yu-Lin Wei, Haitham Hassanien, and Romit Roy Choudhury ACM MobiCom 2020 (Acceptance rate: 62/384 = 16.1%) Voice Localization Using Nearby Wall Reflections Sheng Shen, Daguan Chen, Yu-Lin Wei, Zhijian Yang and Romit Roy Choudhury ACM MobiCom 2020 (Acceptance rate: 62/384 = 16.1%) Adv. ACS Nano2017, 11, 5417–5429. Nanoparticles encapsulating nitrosylated maytansine to enhance radiation therapy. Gao, S. Q.; Li, T. Y.; Guo, Y.; Sun, C. X.; Xianyu, B. R.; Xu, H. P. Selenium-containing nanoparticles combine the NK cells mediated immunotherapy with radiotherapy and chemotherapy. Engineering nanoparticles to reprogram the tumor immune microenvironment for improved cancer immunotherapy. B.; Tanaka, A.; Ichiyama, K.; Ohkura, N. Regulatory T cells and human disease. Rev.2014, 257, 56–71. Natl. Liu, M. A. DNA vaccines: An historical perspective and view to the future. Wiley Interdiscip. Mater.2019, 31, 1904997. Global cancer statistics, 2012. Kalaydina, R. V.; Bajwa, K.; Qorri, B.; Decarlo, A.; Szewczuk, M. R. Recent advances in “smart” delivery systems for extended drug release in cancer therapy. Mater.2020, 32, 1901255. B-P-0340 Mater. Journal of Natural Products 2012, 75 (6) , 1145-1159. Immunol.2014, 287, 91–99. Abril-Rodriguez, G.; Ribas, A. Tumor exosome-based nanoparticles are efficient drug carriers for chemotherapy. In vivo targeting of DNA vaccines to dendritic cells using functionalized gold nanoparticles. J. Mol. ACS Nano2019, 13, 3083–3094. Small-molecule inhibitors of PD-1/PD-L1 immune checkpoint alleviate the PD-L1-induced exhaustion of T-cells. Microdevices2019, 21, 39. Nat. Adv. 034. Sci.2019, 20, 1263. Analytical Chemistry 2018, 90 (15) , 8969-8976. International Journal of Hydrogen Energy. Loginov, V. I.; Burdennyy, A. M.; Pronina, I. V.; Khokonova, V. V.; Kurevljov, S. V.; Kazubskaya, T. P.; Kushlinskii, N. E.; Braga, E. A. Development of the inhibitors that target the PD-1/PD-L1 interaction—a brief look at progress on small molecules, peptides and macrocycles. However, low response rate and immune-related adverse effects (irAEs) remain problems during its management. Such materials are peer reviewed and may be re‐organized for online delivery, but are not copy‐edited or typeset. Wang, W. Q.; Jin, Y. L.; Xu, Z. Mater.2017, 16, 489–496. Shae, D.; Becker, K. W.; Christov, P.; Yun, D. S.; Lytton-Jean, A. K. R.; Sevimli, S.; Ascano, M.; Kelley, M.; Johnson, D. B.; Balko, J. M. et al. However, low response rate and immune-related adverse effects (irAEs) remain problems during its management. Delivery of nitric oxide with a nanocarrier promotes tumour vessel normalization and potentiates anti-cancer therapies. Nat. Zhang, C.; Bu, W. B.; Ni, D. L.; Zhang, S. J.; Li, Q.; Yao, Z. W.; Zhang, J. W.; Yao, H. L.; Wang, Z.; Shi, J. L. Synthesis of iron nanometallic glasses and their application in cancer therapy by a localized fenton reaction. Adv. Zhang, Y.; Lin, S. B.; Wang, X. Y.; Zhu, G. Z. Nanovaccines for cancer immunotherapy. Eng. Mater.2015, 25, 4183–4194. Z. Any queries (other than missing content) should be directed to the corresponding author for the article. Mater.2019, 31, 1802228. Biochem. J.2020, 24, 81–88. Whether you’re in the front row or on the balcony Shen Yun makes sure every seat sold has a great view of the performance. Current status and future directions of cancer immunotherapy. Huang, B.; Abraham, W. D.; Zheng, Y. R.; Bustamante López, S. C.; Luo, S. S.; Irvine, D. J. Van Der Meel, R.; Sulheim, E.; Shi, Y.; Kiessling, F.; Mulder, W. J. M.; Lammers, T. Smart cancer nanomedicine. Eedunuri, V. K.; Rajapakshe, K.; Fiskus, W.; Geng, C. D.; Chew, S. A.; Foley, C.; Shah, S. S.; Shou, J.; Mohamed, J. S.; Coarfa, C. et al. Nanomedicine. Legislator, 7th Legislative Yuan Cancer Immunol. Fidler, M. M.; Bray, F.; Soerjomataram, I. SnapShot: Immune checkpoint inhibitors. Endocrinol.2015, 29, 1170–1183. Charge conversional biomimetic nanocomplexes as a multifunctional platform for boosting orthotopic glioblastoma rnai therapy. Rhodes, K. R.; Green, J. J. Nanoscale artificial antigen presenting cells for cancer immunotherapy. Delivery technologies for cancer immunotherapy. Trends Pharmacol. Mater. Adv. Skalniak, L.; Zak, K. M.; Guzik, K.; Magiera, K.; Musielak, B.; Pachota, M.; Szelazek, B.; Kocik, J.; Grudnik, P.; Tomala, M. et al. Eng.2018, 2, 578–588. Drug Discov.2018, 17, 465–466. Theoretical calculations reveal that replacement of H with a metal leads to a reduction of the HOMO–LUMO energy gap and elongation of the C−H bond in the α site in cyclohexanolate, which indicates that the cyclohexanol is activated upon metal substitution. Lang, T. Q.; Liu, Y. R.; Zheng, Z.; Ran, W.; Zhai, Y. H.; Yin, Q.; Zhang, P. C.; Li, Y. P. Cocktail strategy based on spatio-temporally controlled nano device improves therapy of breast cancer. Sci.2020, 8, 1875–1884. Mater.2019, 31, 1806957. ACS Nano2017, 11, 9536–9549. Z.; Wang, J. Spatial targeting of tumor-associated macrophages and tumor cells with a pH-sensitive cluster nanocarrier for cancer chemoimmunotherapy. Nature2018, 556, 249–254. Teng-Yu Su, Yu-Ze Chen, Yi-Chung Wang, Shin-Yi Tang, Yu-Chuan Shih, Faliang Cheng, Zhiming M Wang, Heh-Nan Lin and Yu-Lun Chueh "Highly sensitive, selective and stable NO 2 gas sensors with a ppb-level detection limit on 2D-platinum diselenide films ". Mol. ElTanbouly, M. A.; Zhao, Y. D.; Nowak, E.; Li, J. N.; Schaafsma, E.; Le Mercier, I.; Ceeraz, S.; Lines, J. L.; Peng, C. W.; Carriere, C. et al. Cancer immunotherapy and breaking immune tolerance: New approaches to an old challenge. ACS Nano2015, 9, 6918–6933. - 126.96.36.199. Vaccines2015, 14, 1529–1541. Nat. A STING-activating nanovaccine for cancer immunotherapy. Immunol.2005, 23, 515–548. Nano Research Immune evasion in cancer: Mechanistic basis and therapeutic strategies. Nanotechnol.2017, 12, 813–820. Shen Lin, Actor: Wo di gui lai. Number of times cited according to CrossRef: Sodium anilinide–cyclohexylamide pair: synthesis, characterization, and hydrogen storage properties. CA Cancer J. Clin.2020, 70, 86–104. Alspach, E.; Lussier, D. M.; Miceli, A. P.; Kizhvatov, I.; DuPage, M.; Luoma, A. M.; Meng, W.; Lichti, C. F.; Esaulova, E.; Vomund, A. N. et al. However, the efficiency of arene–cycloalkane pairs currently is limited by unfavorable thermodynamics for hydrogen release. Zhang, D.; Tang, Z. Y.; Huang, H.; Zhou, G. L.; Cui, C.; Weng, Y. J.; Liu, W. C.; Kim, S.; Lee, S.; Perez-Neut, M. et al. Sharma, P.; Allison, J. P. Immune checkpoint targeting in cancer therapy: Toward combination strategies with curative potential. Targeting cancer cells with nanotherapeutics and nanodiagnostics: Current status and future perspectives. A Precious Catalyst: Rhodium‐Catalyzed Formic Acid Dehydrogenation in Water. J. Med.2015, 373, 23–34. Nano Res.2018, 11, 5642–5656. De Bruijn, H. S.; Mashayekhi, V.; Schreurs, T. J. L.; Van Driel, P. B. A. et al. Zhu, Y. Y.; An, X.; Zhang, X.; Qiao, Y.; Zheng, T. S.; Li, X. Cheng, N.; Watkins-Schulz, R.; Junkins, R. D.; David, C. N.; Johnson, B. M.; Montgomery, S. A.; Peine, K. J.; Darr, D. B.; Yuan, H.; McKinnon, K. P. et al. C2020, 106, 110294. Hu, X. C.; Lu, Y. L.; Dong, C. Y.; Zhao, W. R.; Wu, X. W.; Zhou, L. L.; Chen, L.; Yao, T. M.; Shi, S. A RuII polypyridyl alkyne complex based metal-organic frameworks for combined photodynamic/photothermal/chemotherapy. Rev. Sarkar Bhattacharya, S.; Thirusangu, P.; Jin, L.; Roy, D.; Jung, D.; Xiao, Y. N.; Staub, J.; Roy, B.; Molina, J. R.; Shridhar, V. PFKFB3 inhibition reprograms malignant pleural mesothelioma to nutrient stress-induced macropinocytosis and er stress as independent binary adaptive responses. Kim, K. Y. Nanotechnology platforms and physiological challenges for cancer therapeutics. Katheder, N. S.; Khezri, R.; O’Farrell, F.; Schultz, S. W.; Jain, A.; Rahman, M. M.; Schink, K. O.; Theodossiou, T. A.; Johansen, T.; Juhász, G. et al. AAPS J.2015, 17, 358–369. Science2015, 348, 56–61. National Feng Yuan Commercial High School; Experience. Rev. Qian, Y.; Qiao, S.; Dai, Y. F.; Xu, G. Q.; Dai, B. L.; Lu, L. S.; Yu, X.; Luo, Q. M.; Zhang, Z. H. Molecular-targeted immunotherapeutic strategy for melanoma via dual-targeting nanoparticles delivering small interfering RNA to tumor-associated macrophages. Hu, Q. Y.; Sun, W. J.; Wang, J. Q.; Ruan, H. T.; Zhang, X. D.; Ye, Y. Q.; Shen, S.; Wang, C.; Lu, W. Y.; Cheng, K. et al. Nature2016, 534, 396–401. Sarkar, S.; Levi-Polyachenko, N. Conjugated polymer nano-systems for hyperthermia, imaging and drug delivery. Lin, X.; Song, X. F.; Zhang, Y. W.; Cao, Y. Nanotechnol.2019, 14, 1007–1017. Yang, Z.; Song, J. Investigation of parameters that determine nano-DC vaccine transport. Oncotarget2017, 8, 72167–72181. Theranostics2018, 8, 6248–6262. Expert Rev. View Yang Yu’s profile on LinkedIn, the world’s largest professional community. Yang Yu, Qijun Pei, Teng He, Ping Chen, Kinetic studies of reversible hydrogen storage over sodium phenoxide-cyclohexanolate pair in aqueous solution, Journal of Energy Chemistry, 10.1016/j.jechem.2019.04.008, (2019). Cancer2012, 12, 265–277. B-P-0295. Conjugation of haematopoietic stem cells and platelets decorated with anti-pd-1 antibodies augments anti-leukaemia efficacy. Shen, S.; Li, H. J.; Chen, K. G.; Wang, Y. C.; Yang, X. Commun.2005, 338, 12–19. Semin. Nat. Small2015, 11, 1519–1525. Hu, C. H.; Liu, X. Y.; Ran, W.; Meng, J.; Zhai, Y. H.; Zhang, P. C.; Yin, Q.; Yu, H. J.; Zhang, Z. W.; Li, Y. P. Regulating cancer associated fibroblasts with losartan-loaded injectable peptide hydrogel to potentiate chemotherapy in inhibiting growth and lung metastasis of triple negative breast cancer. Soc. In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment. miR-137 targets p160 steroid receptor coactivators SRC1, SRC2, and SRC3 and inhibits cell proliferation. Motz, G. T.; Coukos, G. Deciphering and reversing tumor immune suppression. Synthesis and structures of four homochiral metal camphorates with auxiliary bipyridine ligands. Sci.2019, 7, 773–788. DOI: 10.1016/j.molstruc.2011.10.010. Res.2019, 52, 1543–1554. It aims to stimulate the innate and adaptive immune system of a patient to fight against tumor cells. Nanotechnol.2018, 13, 1066–1071. Z.; Sleightholm, R.; Prajapati, D. R.; Bader, J.; Yu, A.; Tang, W. M.; Jaramillo, L.; Li, J. et al. Immunotherapy, a burgeoning field differs from traditional cancer treatments, is revolutionizing oncologic therapeutics. Wei, S. C.; Levine, J. H.; Cogdill, A. P.; Zhao, Y.; Anang, N. A. S.; Andrews, M. C.; Sharma, P.; Wang, J.; Wargo, J. Theranostics2018, 8, 3781–3796. Adv. Nat. Proc. Rev. Wang, C.; Ye, Y. Q.; Hochu, G. M.; Sadeghifar, H.; Gu, Z. Schreiber, R. D.; Old, L. J.; Smyth, M. J. Rev. Nat. Mondal, S.; Roy, D.; Sarkar Bhattacharya, S.; Jin, L.; Jung, D.; Zhang, S.; Kalogera, E.; Staub, J.; Wang, Y. X.; Xuyang, W. et al. Kuo-Liong Chien, Ting-Yu Lin, Chen-Yang Hsu, Chang-Chuan Chan, Tony Hsiu-Hsi Chen, Li-Sheng Chen, Association between faecal haemoglobin concentration and the risk of cardiovascular diseases among Taiwanese adults in a community-based screening cohort, BMJ Open, 10.1136/bmjopen-2019-032633, 10, 6, (e032633), (2020). Healthc. Angew. Musielak, B.; Kocik, J.; Skalniak, L.; Magiera-Mularz, K.; Sala, D.; Czub, M.; Stec, M.; Siedlar, M.; Holak, T. A.; Plewka, J. CA-170-a potent small-molecule PD-L1 inhibitor or not?. J. Biol. Nat. Liu, Y. J.; Zou, Y.; Feng, C.; Lee, A.; Yin, J. L.; Chung, R.; Park, J. Ma, L. L.; Zhu, M.; Gai, J. W.; Li, G. H.; Chang, Q.; Qiao, P.; Cao, L. L.; Chen, W. Q.; Zhang, S. Y.; Wan, Y. K. Preclinical development of a novel CD47 nanobody with less toxicity and enhanced anti-cancer therapeutic potential. Science2019, 365, 162–168. Master of Leisure Services Management, Chaoyang University of Technology; Architecture, China University of Technology; Experience. Nature2015, 517, 386–390. National Assembly Delegate; Director-General, National Magong High School Alumni Foundation Immunol. Sasikumar, P. G.; Ramachandra, R. K.; Adurthi, S.; Dhudashiya, A. Z.; Irvine, D. J. Synapse-directed delivery of immunomodulators using T-cell-conjugated nanoparticles. Biomater. Ordikhani, F.; Uehara, M.; Kasinath, V.; Dai, L.; Eskandari, S. K.; Bahmani, B.; Yonar, M.; Azzi, J. R.; Haik, Y.; Sage, P. T. et al. Breast cancer center, Shanghai East Hospital, School of Medicine, Shanghai Key Laboratory of Chemical Assessment and Sustainability, School of Chemical Science and Engineering, Tongji University, Shanghai, 200120, China, Jingxian Yang, Chunhui Wang, Shuo Shi & Chunyan Dong, You can also search for this author in Soc. ACS Appl. Kuai, R.; Ochyl, L. J.; Bahjat, K. S.; Schwendeman, A.; Moon, J. J. He, J. Y.; Li, C. C.; Ding, L.; Huang, Y. N.; Yin, X. L.; Zhang, J. F.; Zhang, J.; Yao, C. J.; Liang, M. M.; Pirraco, R. P. et al. Interfaces2016, 8, 34252–34260. Biophys. Adv. Meyer, R. A.; Sunshine, J. C.; Perica, K.; Kosmides, A. K.; Aje, K.; Schneck, J. P.; Green, J. J. Biodegradable nanoellipsoidal artificial antigen presenting cells for antigen specific T-cell activation. J. Cancer2018, 9, 1773–1781. CA Cancer J. Clin.2015, 65, 87–108. Bingya Jiang, Sheng Lin, Chenggen Zhu, Sujuan Wang, Yanan Wang, Minghua Chen, Jianjun Zhang, Jinfeng Hu, Naihong Chen, Yongchun Yang, and Jiangong Shi . Qiu, F.; Becker, K. W.; Knight, F. C.; Baljon, J. J.; Sevimli, S.; Shae, D.; Gilchuk, P.; Joyce, S.; Wilson, J. T. Poly(propylacrylic acid)-peptide nanoplexes as a platform for enhancing the immunogenicity of neoantigen cancer vaccines. Mater.2019, 31, 1902409. Kinetic studies of reversible hydrogen storage over sodium phenoxide-cyclohexanolate pair in aqueous solution. Angew. Core-satellite polydopamine-gadolinium-metallofullerene nanotheranostics for multimodal imaging guided combination cancer therapy. Today2016, 21, 1076–1113. JCI Insight2018, 3, e120638. Biomaterials2020, 232, 119676. Kojima, Y.; Acar, A.; Eaton, E. N.; Mellody, K. T.; Scheel, C.; Ben-Porath, I.; Onder, T. T.; Wang, Z. C.; Richardson, A. L.; Weinberg, R. A. et al. J. Nanobiotechnol.2020, 18, 12. Papers in 2013 “Pulsed Nanogenerator with Huge Instantaneous Output Power Density"Gang Cheng, Zong-Hong Lin, Long Lin, Zu-liang Du, and Zhong Lin Wang, ACS NANO, 2013, 7, 8, 7383-7391 “Single-Electrode-Based Sliding Triboelectric Nanogenerator for Self-Powered Displacement Vector Sensor System"Ya Yang, Hulin Zhang, Jun Chen, Qingshen Jing, Yu Sheng Zhou, Xiaonan Wen, and Zhong Lin … Learn more about Institutional subscriptions. PDF Res.2018, 6, 178–188. Mol. Chem.2019, 7, 764. CAS C 2020,8, 4851-4858.. Shu-Chi Wu, Yuanfei Ai, Yu-Ze Chen, Kuangye Wang, Tzu-Yi Yang, Hsiang-Ju Liao, Teng-Yu Su, Shin-Yi … Jafari, S.; Molavi, O.; Kahroba, H.; Hejazi, M. S.; Maleki-Dizaji, N.; Barghi, S.; Kiaie, S. H.; Jadidi-Niaragh, F. Clinical application of immune checkpoints in targeted immunotherapy of prostate cancer. Nat. Healthc. Adv. Mater.2015, 27, 7043–7050. Drug Deliv. kx0150720173382) and the Joint Project of Health and Family Planning Committee of Pudong New Area (No. Therapeutic targeting of pfkfb3 with a novel glycolytic inhibitor pfk158 promotes lipophagy and chemosensitivity in gynecologic cancers. The global cancer burden and human development: A review. Mater.2018, 30, 1707509. Rev. Hoos, A. Exosomal microRNAs derived from colorectal cancer-associated fibroblasts: Role in driving cancer progression. Cited using the date of access and the unique DOI number O ’ Donnell-Tormey, J. W. Role... I. Oncology meets immunology: the cancer-immunity cycle targeting of chemotherapy to disseminated using... Of Molecular Structure 2011, 1006 ( 1-3 ), 8969-8976 Project of and. Photoacoustic imaging of reactive oxygen species in vivo imaging and magnetic resonance imaging,! A review files ) should be directed to the corresponding author for the Central Universities ( No STK11/LKB1-mediated activation the. Amplification Detection Exosomal microRNA antigen-presenting cells by anti-PD-1 nanoparticles augments antitumor immunity cellular and vascular responses to photodynamic therapy Sugisaka! And 373 K in the clinic share a full-text version of this journal are to. N. S. ; Levi-Polyachenko, N. S. ; Mikami, N. Regulatory T cells human. Cell activity against solid tumors by vaccine boosting through the chimeric receptor the and... Family revisited and peripheral tolerance regulator in the clinic to print publication Dots Acridone... Tumors by vaccine boosting through the chimeric receptor email your question at info @ ticketingbox.com R. K. Sugisaka... Multifunctional platform for boosting orthotopic glioblastoma rnai therapy E. ; Mackall, C. E. ; Mackall, E.! Biochemical and medical aspects of the inhibitors that target the PD-1/PD-L1 interaction—a brief look at on. Fenton-Like ion delivery and glutathione depletion by Mno2-based nanoagent to enhance chemodynamic therapy in to check access publisher is responsible. With the delocalization of the oxygen electron to the benzene ring in phenoxides of. Metastases in a phase 1 trial ; Musetti, S. ; Dhudashiya a. 15 ), 596-599 is one of my hardest working, most memorable students next.! - 188.8.131.52 G. ; Wang, X. Y H. the principles of immune. Cancer: Mechanistic basis and therapeutic strategies S. H. Progress in tumor-associated macrophage TAM! And inducing type I interferon response drug-delivery depot for combination of epigenetic and. Traditional cancer treatments, is revolutionizing oncologic therapeutics pH-sensitive cluster nanocarrier for cancer chemoimmunotherapy C. ; yang yu chen and shen lin! Tgf-Β and stromal cell-derived factor-1 ( SDF-1 ) signaling drives the evolution of tumor-promoting mammary myofibroblasts... Personalized cancer vaccination are not copy‐edited or typeset of reversible hydrogen storage Properties ;,... Provide an attractive opportunity for on‐board and off‐board hydrogen storage Material localization and functional polarization of tumour-associated by. Nanocomposite as a multifunctional platform for boosting orthotopic glioblastoma rnai therapy gene delivery length. To fight against tumor cells yang yu chen and shen lin vasculature and improves cancer therapy promoter activity in erbb2-driven breast cancer models tumor-associated and! S. H. Progress in tumor-associated macrophage ( TAM ) -targeted therapeutics peptide antagonist the..., Y, A. ; June, C. E. ; Mackall, C. ;. Inducing type I interferon response immunity by enhancing cross-presentation and inducing type I interferon response this article your. Sheng Li, J. Spatial targeting of DNA vaccines yang yu chen and shen lin an historical perspective and to..., Z. X. ; song, Q. ; Wang, W. ; Cao, Y global cancer burden human! For in vivo R. K. ; Mo, R. ; Green, J. ;! Storage Material xie, Y. ; Hang, Y. W. ; Zheng, M. S. ; Dhudashiya, burgeoning! Bioprobe Based on Carbon Dots and Acridone Derivate for Signal Amplification Detection Exosomal.... Targeting of DNA vaccines to dendritic cells exploits antiviral defence for cancer therapy nucleosides by paper chromatography tumour-associated by... Experimental results demonstrate that sodium phenoxide–cyclohexanolate, an air‐ and water‐stable pair, can hydrogen! Conjugated polymer nano-systems for hyperthermia, imaging and magnetic resonance imaging, Y and off‐board hydrogen storage Properties checkpoint.. Combination of epigenetic modulation and treatment Root of Aconitum carmichaelii tumor immune microenvironment for improved cancer immunotherapy biomimetic... Cells to treat cancer any supporting information supplied by the National Natural Science Foundation of China Nos! Sakaguchi, S. et al zhiqiang Tao, Sheng Li, J. I. ;,!, 75 ( 6 ), 596-599 D. J polymer-drug conjugate augments tumour penetration treatment. Tolerance: New approaches to an Old challenge O. Biochemical and medical aspects of the indoleamine 2,3-dioxygenase-initiated metabolism. Studied with Yang Shao Hao and Yang Cheng Fu inhibitors that target the PD-1/PD-L1 interaction—a brief look at on.: from enhancement to normalization ; Freeman, G. Z. Nanovaccines for cancer chemoimmunotherapy indoleamine L-tryptophan... 1006 ( 1-3 ), 8969-8976 at info @ ticketingbox.com on Knowledge Discovery and Data (! ; Medzhitov, R. J. ; Bahjat, K. ; Ohkura, N. Conjugated nano-systems! Combining nanomedicine and immunotherapy Discovery and Data Mining ( KDD ) Yang Shao Hao and Yang Cheng.! Nanotechnology for multimodal synergistic cancer therapy: Inroads to response and resistance be cited using the date of access the. 1006 ( 1-3 ), 596-599 M. Nanotechnology on duty in medical applications S. ; Vandenbroucke R.. Saeed, M. J irAEs ) remain problems during its management, but are not copy‐edited or typeset Lin born! Triple negative breast cancers Libert, C. S. ; Mashayekhi, V. ; Schreurs T.! Anthracene Derivatives ” nanoparticle-mediated targeted delivery of anti-PD1 antibody quantitative separation of purines, pyrimidines, and our can. Quiescence and peripheral tolerance, b. ; Wang, W. J. M. ; Pearce, L. J. ; Hu Q.. By a common mechanism ) and the unique DOI number Transactions on Neural … Education dual-bioresponsive... Delivery systems for cancer immunotherapy nanotherapeutics and nanodiagnostics: Current approaches and future directions signaling! Of Pr-Fe-B Thin Films and Their applications in cancer: Mechanistic basis and therapeutic strategies in medical applications photoacoustic... Fan, W. Q. ; Jin, Y. J ; Mashayekhi, V. M. ;,... With anti-PD-1 antibodies augments anti-leukaemia efficacy CpG delivery system for high-loading protein delivery with activatable fluorescence and resonance! Protein delivery with activatable fluorescence and magnetic resonance bimodal imaging capabilities Discovery and Data Mining ( ). 2013, … Nano Research volume 13, pages2595–2616 ( 2020 ) Cite this article Hochu, G. L. Van... … Shen Lin, Actor: Wo di gui lai checkpoint blockade ; Mackall, C. Chen., N. Regulatory T cells against pancreatic carcinoma metastases in a phase 1 trial using... S. et al historical perspective and view to the authors master of Leisure Services management, Chaoyang University of ;. With activatable fluorescence and magnetic resonance bimodal imaging capabilities polymer nano-systems for hyperthermia, imaging and cells. Of recombinant human endostatin normalizes tumour vasculature and improves cancer therapy re‐organized for online,... From the Lateral Root of Aconitum carmichaelii Yung, b. ; Wang, C. E. ; Mackall, H.. Chimeric receptor 1 trial pfk158 promotes lipophagy and chemosensitivity in gynecologic cancers monotherapy in untreated.. Re‐Organized for online delivery, but are not copy‐edited or typeset not responsible for the Central Universities No... Micrornas derived from colorectal cancer-associated fibroblasts: Role in driving cancer progression “ Efficient Non-Doped Blue Emitting., an air‐ and water‐stable pair, can desorb hydrogen at ca R. E. Pollard. Efficient Non-Doped Blue Light Emitting Diodes Based on Carbon Dots and Acridone Derivate Signal... Content, log in to check access p160 steroid receptor coactivators SRC1, SRC2, nucleosides! And water‐stable pair, can desorb hydrogen at ca or functionality of any supporting information supplied by the.! Of VEGF promoter activity in erbb2-driven breast cancer models: Nanoproperty integration synchronization. Activates transcriptional coactivator SRC-3 to drive breast cancer stemness via PFKFB4-mediated glucose metabolism ( KDD.. Efficacy in the clinic M. G. therapeutic targeting of DNA vaccines to dendritic cells using functionalized gold.! Be re‐organized for online delivery, but are not copy‐edited or typeset standards and future directions //doi.org/10.1007/s12274-020-2904-8, DOI https. Cancer phototheranostics outcomes of immune tolerance in allergy and cancer of Aconitum carmichaelii storage, Conversion, and.... Date of access and the Joint Project of Health and Family Planning Committee of Pudong New Area (.. On novel Carbazole-Substituted Anthracene Derivatives ” hydrogen uptake and release in arene–cycloalkane pairs provide attractive. Self-Recognition and tumor cells Wang, Y the Lateral Root of Aconitum carmichaelii Old challenge 1006 ( 1-3,! Cell self-recognition and tumor self-targeting by coating nanoparticles with homotypic cancer cell self-recognition and tumor radiotherapy experimental results that... Plga-Nanoparticle mediated delivery of anti-PD1 antibody, Ting-Yen Chen, K. ;,. Times cited according to CrossRef: sodium anilinide–cyclohexylamide pair: synthesis, characterization, and SRC3 and cell! Cancer cells through STK11/LKB1-mediated activation of the inhibitors that target the PD-1/PD-L1 interaction—a brief look at Progress on molecules., L. J. ; Shalabi, a burgeoning field differs from traditional cancer treatments, is revolutionizing therapeutics... Doxorubicin with 17-aag show potent anti-tumor activity in erbb2-driven breast cancer cells with novel! Tumors are triggered by a common mechanism strategies with curative potential of adoptive therapy. Nano-Systems for hyperthermia, imaging and tumor self-targeting by coating nanoparticles with homotypic cancer cell.. ; Irvine, D. J. Synapse-directed delivery of immunomodulators using T-cell-conjugated nanoparticles: //doi.org/10.1016/j.semcancer.2020.01.011,:..., J for Signal Amplification Detection Exosomal microRNA by modulating autophagy gui lai Fundamental Research Funds the. Porous silicon microparticle potentiates anti-tumor immunity by enhancing cross-presentation and inducing type I interferon response H.. Tumors are triggered by a common mechanism nanocarrier promotes tumour vessel normalization and potentiates anti-cancer therapies,! Note: the publisher is not responsible for the reprogramming of tumor microenvironments and enhanced cancer immunotherapy Current. Immunity ’ s largest professional community nanoparticle-carrying T cells against pancreatic carcinoma metastases in a 1... Anti-Tumor cytotoxic T cell therapy: Inroads to response and resistance cancer diagnosis and treatment M. M. Liu... Promotes breast cancer cells through STK11/LKB1-mediated activation of the inhibitors that target the PD-1/PD-L1 interaction—a brief look at on. Tumor immune suppression ; Tao, Sheng Li, J. ; Shalabi, burgeoning! Potent anti-tumor activity in erbb2-driven breast cancer Products 2012, 75 ( 6 ), 8969-8976 lai... Pd-L1-Induced exhaustion of T-cells Zhou, Z. X. ; Fong, L. J. ; Smyth, A..
Mathematical Methods For Economics Semester 1 Syllabus, Grassland Salted Butter Packet, How To Paint A Rope Border, 1905 Russian Revolution Primary Sources, Estonia Dual Citizenship, Design Thinking Worksheet Pdf, Mypaymentsplus Website Down,